留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

视神经鞘直径指导神经胶质瘤手术患者脱水治疗的可行性研究

夏文华 孙翔 邵建林

夏文华, 孙翔, 邵建林. 视神经鞘直径指导神经胶质瘤手术患者脱水治疗的可行性研究[J]. 昆明医科大学学报, 2022, 43(6): 117-121. doi: 10.12259/j.issn.2095-610X.S20220620
引用本文: 夏文华, 孙翔, 邵建林. 视神经鞘直径指导神经胶质瘤手术患者脱水治疗的可行性研究[J]. 昆明医科大学学报, 2022, 43(6): 117-121. doi: 10.12259/j.issn.2095-610X.S20220620
Wenhua XIA, Xiang SUN, Jianlin SHAO. Feasibility of Optic Nerve Sheath Diameter to Guide the Treatment of Dehydration in Patients Undergoing Glioma Surgery[J]. Journal of Kunming Medical University, 2022, 43(6): 117-121. doi: 10.12259/j.issn.2095-610X.S20220620
Citation: Wenhua XIA, Xiang SUN, Jianlin SHAO. Feasibility of Optic Nerve Sheath Diameter to Guide the Treatment of Dehydration in Patients Undergoing Glioma Surgery[J]. Journal of Kunming Medical University, 2022, 43(6): 117-121. doi: 10.12259/j.issn.2095-610X.S20220620

视神经鞘直径指导神经胶质瘤手术患者脱水治疗的可行性研究

doi: 10.12259/j.issn.2095-610X.S20220620
基金项目: 老年围术期质量改善技术方案应用与示范研究(2018YFC2001805);云岭产业技术领军人才培养项目(2017FE468-034)
详细信息
    作者简介:

    夏文华(1994~),女,云南昆明人,医学硕士,住院医师,主要从事临床麻醉研究工作

    孙翔与夏文华对本文有同等贡献

    通讯作者:

    邵建林,E-mail:cmushaojl@aliyun.com

  • 中图分类号: R614

Feasibility of Optic Nerve Sheath Diameter to Guide the Treatment of Dehydration in Patients Undergoing Glioma Surgery

  • 摘要:   目的   探讨超声测量视神经鞘直径(ONSD)对神经胶质瘤手术患者颅高压(ICH)脱水治疗效果的可行性。  方法   选取择期行额部神经胶质瘤切除术的颅高压患者共40例,随机分为2组(n = 20)。在气管插管10 min后,甘露醇组(M组)予20%甘露醇0.5 g/kg在15 min内静脉滴注完毕,对照组(C组)予等量生理盐水在15 min内静脉滴注完毕。测量麻醉诱导前(T0)、气管插管后即刻(T1)、药物开始滴注时(T2)、药物滴注完毕后30 min(T3)、手术结束即刻(T4)、术后24 h(T5)双眼的ONSD值。检测各时刻血清中VEGF-A、MMP-9和ET-1水平。记录打开硬脑膜时的大脑松弛评分(BRS)。  结果   T3、T4、T5时刻,M组患者的ONSD值、血清中VEGF-A 、MMP-9、ET-1的浓度明显低于C组患者(P < 0.05);M组患者的BRS评分明显低于C组患者(P < 0.05)。  结论   对术前存在颅内高压的神经胶质瘤患者,在视神经鞘直径的指导下提前给予脱水治疗,可有效减轻脑水肿。
  • 图  1  T0-T6各时刻视神经鞘直径的超声图像

    Figure  1.  Ultrasonic image of optic nerve sheath diameter at each time from T0 to T6

    表  1  2组患者一般情况的比较($\bar x \pm s $,n = 20)

    Table  1.   Comparison of general conditions between two groups of patients($\bar {\boldsymbol{x}} \pm {\boldsymbol{s}}$,n = 20)

    组别年龄
    (岁)
    性别
    男/女(n)
    BMI
    (kg/m2
    ASAI/II
    (n)
    肿瘤位置
    左/右(n)
    肿瘤体积
    (cm3
    C组 41.7 ± 9.8 8/12 21.9 ± 1.1 10/10 11/9 44.5 ± 2.7
    M组 41.4 ± 10.1 11/9 22.0 ± 1.0 11/9 13/7 45.6 ± 2.4
    t/χ2 0.006 0.902 0.121 0.100 0.417 1.935
    P 0.937 0.342 0.730 0.752 0.519 0.172
    下载: 导出CSV

    表  2  2组患者在不同时刻双侧ONSD值的比较($\bar x \pm s $,n = 20,mm)

    Table  2.   Comparison of bilateral ONSD values between two groups at different time($\bar {\boldsymbol{x}} \pm {\boldsymbol{s}}$,n = 20,mm)

    部位组别T0T1T2T3T4T5
    左侧 C组 6.31 ± 0.28 7.18 ± 0.35* 6.31 ± 0.28 6.29 ± 0.30 4.99 ± 0.18* 5.51 ± 0.16*
    M组
    6.43 ± 0.29 7.26 ± 0.37* 6.43 ± 0.28 6.00 ± 0.24*# 4.46 ± 0.19*# 5.10 ± 0.20*#
    F 2.410 0.729 2.128 14.948 128.119 78.090
    P 0.137 0.404 0.161 < 0.01# < 0.01# < 0.01#
    右侧 C组 6.22 ± 0.21 7.00 ± 0.23* 6.21 ± 0.18 6.18 ± 0.12 4.82 ± 0.10* 5.38 ± 0.08*
    M组 6.24 ± 0.22 7.03 ± 0.16* 6.25 ± 0.20 5.89 ± 0.19*# 4.41 ± 0.19*# 4.93 ± 0.20*#
    F 0.416 0.222 1.976 60.181 105.733 90.717
    P 0.527 0.643 0.176 < 0.01# < 0.01# < 0.01#
      与T0时刻比较,*P < 0.05;与C组比较,#P < 0.05
    下载: 导出CSV

    表  3  2组患者BRS评分的比较($\bar x \pm s$,n = 20,分)

    Table  3.   Comparison of BRS score between two groups($\bar {\boldsymbol{x}} \pm{\boldsymbol{ s}}$,n = 20,Points)

    组别BRS评分
    C组 3.0 ± 0.6
    M组 1.7 ± 0.5#
    t 5.814
    P < 0.01#
      与C组比较,#P < 0.05。
    下载: 导出CSV

    表  4  2组患者在不同时刻血清VEGF-A、MMP-9、ET-1浓度的比较($\bar x \pm s $,n = 20,pg/mL)

    Table  4.   Comparison of serum VEGF-A, MMP-9 and ET-1 concentrations between 2 groups at different time points($\bar {\boldsymbol{x}} \pm {\boldsymbol{s}}$,n = 20,pg/mL)

    指标组别T0T3T4T5
    VEGF-A C组 162.11 ± 9.60 161.56 ± 9.52 143.29 ± 10.33* 158.15 ± 10.05*
    M组 160.59 ± 11.61 149.14 ± 11.32*# 123.01 ± 11.44*# 130.18 ± 10.10*#
    F 1.084 59.675 102.747 90.252
    P 0.311 < 0.01# < 0.01# < 0.01#
    MMP-9 C组 23.28 ± 2.72 23.53 ± 2.51 19.15 ± 2.59* 20.71 ± 2.07*
    M组 23.41 ± 2.78 19.70 ± 2.43*# 15.52 ± 2.16*# 17.38 ± 1.94*#
    F 0.459 285.752 280.944 126.377
    P 0.506 < 0.01# < 0.01# < 0.01#
    ET-1 C组 86.74 ± 8.30 86.34 ± 7.79 67.68 ± 8.87* 73.89 ± 8.54*
    M组 86.40 ± 9.14 80.08 ± 7.35*# 52.52 ± 8.70*# 64.20 ± 8.05*#
    F 0.245 63.927 515.625 171.555
    P 0.626 < 0.01# < 0.01# < 0.01#
      与T0时刻比较,*P < 0.05;与C组比较,#P < 0.05。
    下载: 导出CSV
  • [1] Lapointe S,Perry A,Butowski NA. Primary brain tumours in adults[J]. Lancet,2018,392(10145):432-446. doi: 10.1016/S0140-6736(18)30990-5
    [2] Murayi R,Chittiboina P. Glucocorticoids in the management of peritumoral brain edema:a review of molecular mechanisms[J]. Childs Nerv Syst,2016,32(12):2293-2302. doi: 10.1007/s00381-016-3240-x
    [3] Boer C,Franschman G,Loer SA. Prehospital management of severe traumatic brain injury:concepts and ongoing controversies[J]. Curr Opin Anaesthesiol,2012,25(5):556-562. doi: 10.1097/ACO.0b013e328357225c
    [4] Robba C,Santori G,Czosnyka M,et al. Optic nerve sheath diameter measured sonographically as non-invasive estimator of intracranial pressure:a systematic review and meta-analysis[J]. Intensive Care Med,2018,44(8):1284-1294. doi: 10.1007/s00134-018-5305-7
    [5] Hernández-Palazón J,Fuentes-García D,Doménech-Asensi P,et al. A dose-response relationship study of hypertonic saline on brain relaxation during supratentorial brain tumour craniotomy[J]. Br J Neurosurg,2018,32(6):619-627. doi: 10.1080/02688697.2018.1508640
    [6] Sharma HS,Muresanu DF,Castellani RJ,et al. Pathophysiology of blood-brain barrier in brain tumor. Novel therapeutic advances using nanomedicine[J]. Int Rev Neurobiol,2020,151(5):1-66.
    [7] Berhouma M,Jacquesson T,Jouanneau E,et al. Pathogenesis of peri-tumoral edema in intracranial meningiomas[J]. Neurosurg Rev,2019,42(1):59-71. doi: 10.1007/s10143-017-0897-x
    [8] Hanafi MG,Verki MM,Parei SN. Ultrasonic Assessment of Optic Nerve Sheath to Detect Increased Intracranial Pressure[J]. J Med Ultrasound,2019,27(2):69-74. doi: 10.4103/JMU.JMU_54_18
    [9] Zhang X,Medow JE,Iskandar BJ,et al. Invasive and noninvasive means of measuring intracranial pressure:a review[J]. Physiol Meas,2017,38(8):R143-R182. doi: 10.1088/1361-6579/aa7256
    [10] Wang J,Li K,Li H,et al. Ultrasonographic optic nerve sheath diameter correlation with ICP and accuracy as a tool for noninvasive surrogate ICP measurement in patients with decompressive craniotomy[J]. J Neurosurg,2019,133(7):1-7.
    [11] Munawar K,Khan MT,Hussain SW,et al. Optic Nerve Sheath Diameter Correlation with Elevated Intracranial Pressure Determined via Ultrasound[J]. Cureus,2019,11(2):e4145.
    [12] Bäuerle J,Nedelmann M. Sonographic assessment of the optic nerve sheath in idiopathic intracranial hypertension[J]. J Neurol,2011,258(11):2014-2019. doi: 10.1007/s00415-011-6059-0
    [13] Demirgan S,Özcan FG,Gemici EK,et al. Reverse Trendelenburg position applied prior to pneumoperitoneum prevents excessive increase in optic nerve sheath diameter in laparoscopic cholecystectomy:randomized controlled trial[J]. J Clin Monit Comput,2021,35(1):89-99. doi: 10.1007/s10877-020-00608-6
    [14] Martin M,Lobo D,Bitot V,et al. Prediction of Early Intracranial Hypertension After Severe Traumatic Brain Injury:A Prospective Study[J]. World Neurosurg,2019,127(7):e1242-e1248.
    [15] Rasmussen M,Bundgaard H,Cold GE. Craniotomy for supratentorial brain tumors:risk factors for brain swelling after opening the dura mater[J]. J Neurosurg,2004,101(4):621-626. doi: 10.3171/jns.2004.101.4.0621
    [16] Launey Y,Nesseler N,Le Maguet P,et al. Effect of osmotherapy on optic nerve sheath diameter in patients with increased intracranial pressure[J]. J Neurotrauma,2014,31(10):984-988. doi: 10.1089/neu.2012.2829
    [17] Nowacka A,Smuczyński W,Rość D,et al. Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors[J]. PLoS One,2018,13(3):e0192395. doi: 10.1371/journal.pone.0192395
    [18] Yang J,Wang T,Jin X,et al. Roles of Crosstalk between Astrocytes and Microglia in Triggering Neuroinflammation and Brain Edema Formation in 1,2-Dichloroethane-Intoxicated Mice[J]. Cells,2021,10(10):2647. doi: 10.3390/cells10102647
    [19] Liu T,Liao XZ,Zhou MT. Ulinastatin alleviates traumatic brain injury by reducing endothelin-1[J]. Transl Neurosci,2021,12(1):1-8.
  • [1] 康旭, 陈若平, 王晓强.  裂隙脑室综合征的诊断治疗新进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210528
    [2] 苏星, 施炜, 张宇, 施金龙, 陈建国, 沈剑虹, 陈建, 白鹏.  经扩大椎间孔入路显微切除椎管内外哑铃形神经鞘瘤, 昆明医科大学学报.
    [3] 李峰.  脑神经胶质瘤患者脑脊液TSGF及HGF水平对细胞外基质重构的影响, 昆明医科大学学报.
    [4] 郭红伟.  神经外科术后颅内感染50例临床治疗观察, 昆明医科大学学报.
    [5] 王静.  AMH-T体外抗肿瘤作用的研究, 昆明医科大学学报.
    [6] 刘博虎.  不同包扎方法对标准去骨瓣减压术后患者颅内压的影响, 昆明医科大学学报.
    [7] 罗剑渊.  26例支架辅助栓塞颅内宽颈动脉瘤的疗效分析, 昆明医科大学学报.
    [8] 杨明.  MEMRI在受损视神经诊断中的应用, 昆明医科大学学报.
    [9] 李东波.  颅内破裂动脉瘤的诊断研究, 昆明医科大学学报.
    [10] 魏亚辉.  IGF-2及IGFBP-2与脑神经胶质瘤侵袭能力的相关性分析, 昆明医科大学学报.
    [11] 魏亚辉.  FTS理念在神经胶质瘤切除术中的应用效果分析, 昆明医科大学学报.
    [12] 张金鹏.  颅内未破裂动脉瘤43例临床体会, 昆明医科大学学报.
    [13] 王为.  颅内动脉瘤夹闭术围手术期护理体会, 昆明医科大学学报.
    [14] 张明.  开颅手术夹闭治疗47例颅内破裂动脉瘤体会, 昆明医科大学学报.
    [15] 谷震.  双微导管技术治疗颅内宽颈动脉瘤28例体会, 昆明医科大学学报.
    [16] 李滋聪.  DECTA对颅内微小动脉瘤的诊断价值, 昆明医科大学学报.
    [17] 苏松.  颅内大型脑膜瘤的显微手术疗效观察, 昆明医科大学学报.
    [18] 颅内动脉瘤显微手术围手术期护理, 昆明医科大学学报.
    [19] 外周神经鞘瘤的超声诊断及误诊分析, 昆明医科大学学报.
    [20] 唐茂丹.  大鼠视神经切断后视网膜Muller细胞及小胶质细胞变化特点, 昆明医科大学学报.
  • 加载中
图(1) / 表(4)
计量
  • 文章访问数:  1808
  • HTML全文浏览量:  1492
  • PDF下载量:  8
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-02-08
  • 网络出版日期:  2022-06-07
  • 刊出日期:  2022-06-30

目录

    /

    返回文章
    返回